<qa>  What is the name of the vaccine that is acceptable for patients who have received immunotherapy within 6- Patients who have received immunotherapy interferons, tumor necrosis factor, other cytokines e.g., interleukins or biological response modifiers, or BCG vaccines within 6 weeks of receiving their first dose of study medication. Patients who have received hemopoietic factors are acceptable. 